Viewing Study NCT00054418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2026-01-26 @ 9:22 PM
Study NCT ID: NCT00054418
Status: COMPLETED
Last Update Posted: 2016-07-13
First Post: 2003-02-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Osteoporosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None osteoporosis View
None stage I breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View